510(k) · Cleared
ClearedLyphochek Coagulation Control, Level 4, Model 743
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Bio-Rad · GGN Plasma, Coagulation Control
Cleared on Sep 17, 2003 as substantially equivalent to K012722 (Bio-Rad, 2001) after a 23-day review. Its family tree reaches back 4 generations to 1982.
- Decided
- Sep 17, 2003
- Review
- 23 days
- Class
- Class II
- Product code
- GGN
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 4 generations to K820450 (1982). No later device cites it as a predicate yet.
- Root · 4 generations backK820450 ThromboscreenPacific Hemostasis · 1982
- 3 generations backK964963 Lyphochek Coagulation ControlBio-Rad · 1997
- 2 generations backK990858 Lypochek Coagulation Control, Model Nos. 787, 788, 789Bio-Rad · 1999
- 1 generation backK012722 Lyphochek Coagulation Control Level 1, Lyphochek Coagulation Level…Bio-Rad · 2001
- This deviceK032611 Lyphochek Coagulation Control, Level 4, Model 743Bio-Rad · 2003
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K820450 | Thromboscreen | Pacific Hemostasis | 1982 | — |
| −3 | K964963 | Lyphochek Coagulation Control | Bio-Rad | 1997 | — |
| −2 | K990858 | Lypochek Coagulation Control, Model Nos. 787, 788, 789 | Bio-Rad | 1999 | — |
| −1 | K012722 | Lyphochek Coagulation Control Level 1, Lyphochek Coagulation Level 2… | Bio-Rad | 2001 | — |
| 0 (this device) | K032611 | Lyphochek Coagulation Control, Level 4, Model 743 | Bio-Rad | 2003 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GGN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K012722 | Lyphochek Coagulation Control Level 1, Lyphochek Coagulation Level 2, Lyphochek…Summary page 2…ics LyphochekB Coagulation Control LyphochekB Coagulation Control (Predicate Device K012722) (New Device) the precision of citrated coagulation sy… | 2001 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 21 years and passes through 2 companies; a new generation was cleared every 2.4 years on median.
- None of the 4 ancestors has a recall.
How does its category compare?
All GGN devicesGGN Plasma, Coagulation Control: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GGN
4in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · GGN
96in 2017
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GGN
1in 2019
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GGN
4in 2018
MAUDE reports naming product code GGN, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 47 | 0 | 0 |
| 2008 | 1 | — | 0 | 0 |
| 2009 | 2 | — | 0 | 37 |
| 2010 | 3 | 23 | 4 | 17 |
| 2011 | 2 | — | 1 | 30 |
| 2012 | 1 | — | 0 | 10 |
| 2013 | 3 | 441 | 3 | 9 |
| 2014 | 2 | — | 0 | 5 |
| 2015 | 0 | — | 0 | 10 |
| 2016 | 2 | — | 0 | 9 |
| 2017 | 4 | 96 | 0 | 11 |
| 2018 | 0 | — | 0 | 4 |
| 2019 | 0 | — | 1 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 2 | — |
What is it indicated for?
Lyphochek@Coagulation Control is intended for use as a quality control plasma to
monitor the precision of citrated coagulation systems.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K032611 · printed Nov 6, 2026
Cite this page
510(k) Report. “K032611: Lyphochek Coagulation Control, Level 4, Model 743.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032611
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026